Drug Amount Reporting: FDA Publicly Identifies over 7,700 Noncompliant Companies May 1, 2026 By Fabiola C. Gomez, Ph.D., CMC Regulatory Expert —

https://www.thefdalawblog.com/2026/05/drug-amount-reporting-fda-publicly-identifies-over-7700-noncompliant-companies/?utm_source=rss&utm_medium=rss&utm_campaign=drug-amount-reporting-fda-publicly-identifies-over-7700-noncompliant-companies On March 31, 2026, the FDA published a list of companies that have not submitted required drug amount reports for calendar year 2024. For stakeholders involved in drug manufacturing, this update highlights both a critical regulatory requirement and a compliance gap across the industry.